Canifarma

What Canifarma does

Canifarma (Cámara Nacional de la Industria Farmacéutica y de Dispositivos Médicos) is the national industry chamber representing pharmaceutical and medical device manufacturers in Mexico, founded in 1945 and headquartered at Av. Cuauhtémoc #1481, Col. Santa Cruz Atoyac, Benito Juárez, Mexico City. Operating as a non-profit membership association under Mexico's Law of Industrial Chambers, it convenes the industry with federal authorities — COFEPRIS, Secretaría de Salud, IMSS, ISSSTE, SAT, SE, and IMPI — to shape regulatory policy, public supply, intellectual property, and industrial strategy. Its published National Pharmaceutical Policy sets strategic axes through 2030 covering public supply, the right to health, regulatory affairs and innovation, and industrial policy.

The chamber's primary digital product is Pharmatramix, a centralized database platform that manages regulatory procedures, deadlines, and typology for submissions before COFEPRIS, providing traceability for members. Beyond this core offering, Canifarma runs commissions and sections (including the INFARVET veterinary pharmaceuticals division), organizes industry events such as the Forum on Rare Diseases, publishes a digital library of commission reports, and has signaled an emerging AI initiative via its website. Its business model is membership-based (affiliates and associates) augmented by service activities; pricing is not publicly disclosed, and no external investors or parent company control the organization.

Name

Canifarma

Legal name

Cámara Nacional de la Industria Farmacéutica

Website

https://canifarma.org.mx

Company type

Private

Founded year

1945

Operating status

Operating

Headcount range

11–50 employees

Short description

Canifarma is Mexico's national pharmaceutical and medical devices industry chamber, founded in 1945, representing manufacturers before government bodies like COFEPRIS and offering members its Pharmatramix regulatory workflow platform and policy advocacy.

Ownership category

akta.pro rank

Product category

Pharmaceutical Industry Association

NAICS

Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Access Policy, Advocacy & Stakeholder Management (HLAIAKAL)

akta.pro secondary industries

Generic ANDA/Regulatory Affairs & Submissions (HLAIABAJ), Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Pharmaceutical industry association
• Medical device manufacturing
• Regulatory affairs services
• Industry chamber membership
• Pharmaceutical policy advocacy

Headquarters

HQ city

Benito Juarez

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels3 records

Core offering

Canifarma is a national industry chamber representing pharmaceutical and medical device manufacturers in Mexico. It provides advocacy, policy engagement, and regulatory support to its member companies, and operates Pharmatramix, a digital platform that centralizes and streamlines management of regulatory procedures before COFEPRIS.

Product overview

Canifarma (Cámara Nacional de la Industria Farmacéutica y de Dispositivos Médicos) operates as an industry chamber representing Mexico's pharmaceutical and medical device sector. The organization's primary digital product is Pharmatramix, a platform for managing regulatory procedures with COFEPRIS. The chamber also provides a digital library of annual reports from various commissions, events organization, and industry guidance through its website, representing over 79 years of promoting the development of Mexico's pharmaceutical industry.

Differentiator

Problem solved

Functional benefit

Brands

• Pharmatramix: A platform designed to optimize the management of procedures for the pharmaceutical industry before COFEPRIS (Federal Commission for Protection against Sanitary Risks), offering centralized access to an exhaustive and updated database.

Products and services

• Pharmatramix
• Industry Chamber Membership
• Industry Forums and Events
• Digital Library
• Industry Directory

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature1 record

Partnerships

Ten partnerships are on record, tiered core and minor.

• COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)coreTechnology or IntegrationCanifarma works closely with COFEPRIS on regulatory matters. The Pharmatramix platform was specifically designed to optimize management of procedures before COFEPRIS, providing a centralized database for tracking administrative procedures and ensuring traceability.
• IMPI (Instituto Mexicano de la Propiedad Industrial)minorStrategic or Co-development PartnerPartnership with Mexico's intellectual property institute for intellectual property protection matters affecting the pharmaceutical industry.
• Secretaría de Salud (Ministry of Health)coreStrategic or Co-development PartnerCollaboration with the Ministry of Health on healthcare policy and ensuring access to innovative treatments.
• ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado)minorStrategic or Co-development PartnerRelationship with the state employees' social security institute for public health supply matters.
• IMSS (Instituto Mexicano del Seguro Social)coreStrategic or Co-development PartnerCollaboration with the Mexican Social Security Institute on public supply and healthcare delivery.
• SAT (Servicio de Administración Tributaria)minorStrategic or Co-development PartnerRelationship with the tax administration service for fiscal matters affecting the pharmaceutical industry.
• SE (Secretaría de Economía)minorStrategic or Co-development PartnerCollaboration with the Ministry of Economy on industrial policy and international trade matters.
• AMIIF (Asociación Mexicana de Industrias Innovadoras de Dispositivos Médicos)minorOthersPartnership with the Mexican Association of Innovative Medical Device Industries.
• ANAFAM (Asociación Nacional de Fabricantes de Medicamentos)minorOthersPartnership with the National Association of Medicine Manufacturers.
• AFAMELA (Asociación de Fabricantes de Materiales y Equipos de Laboratorio)minorOthersPartnership with the Association of Laboratory Equipment and Materials Manufacturers.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• AFAMELA (Asociación de Fabricantes de Materiales y Equipos de Laboratorio): Mexican association of laboratory equipment and materials manufacturers. Direct peer in chamber/association function (industry advocacy, government liaison), covering the laboratory-adjacent segment of Canifarma's broader membership.
• ANAFAM (Asociación Nacional de Fabricantes de Medicamentos): National association of medicine manufacturers in Mexico. Direct functional peer — represents pharmaceutical manufacturers and engages on regulatory and supply issues — but narrower scope than Canifarma, which also covers devices and veterinary.
• AMIIF (Asociación Mexicana de Industrias Innovadoras de Dispositivos Médicos): Mexico's association for innovative medical device manufacturers. Closely comparable function to Canifarma in advocacy, regulatory engagement, and policy work, but focused specifically on the innovative devices segment rather than the full pharma + devices umbrella.

Regional players

• INTERFARMA (Associação da Indústria Farmacêutica de Pesquisa): Brazil's research-based pharmaceutical industry association. Closest functional peer within LATAM — performs advocacy, regulatory engagement, and policy development for pharma manufacturers in the region's largest market.
• ALIFAR (Asociación Latinoamericana de Industrias Farmacéuticas): Latin American association of pharmaceutical industries. Regional peer focused on generics and access policy across LATAM; comparable in advocacy function to Canifarma but operates across multiple national jurisdictions.
• FIFARMA (Federación Latinoamericana de la Industria Farmacéutica): Latin American pharmaceutical industry federation. Directly comparable mission (industry representation, regulatory modernization, access policy) across multiple LATAM countries, complementing national chambers like Canifarma at the regional level.

Broad incumbents

• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations): Global pharma industry federation. Comparable chamber/association function at worldwide scale, providing a template for how Canifarma could expand its influence and partnerships beyond Mexico.
• PhRMA (Pharmaceutical Research and Manufacturers of America): The US pharmaceutical industry's principal trade association. Highly comparable function (advocacy, regulatory policy, public affairs) at much larger scale and budget; serves as the global benchmark for the kind of role Canifarma plays in Mexico.
• EFPIA (European Federation of Pharmaceutical Industries and Associations): European pharma industry's primary trade body. Comparable advocacy, regulatory affairs, and policy representation role, but at continental scope — useful structural parallel even though the jurisdiction differs from Canifarma's domestic Mexican remit.

Emerging players

• INFARVET (Sección de la Industria Farmacéutica Veterinaria): Canifarma's own veterinary pharmaceutical section, but listed here as a comparable industry-association structure focused on a sub-segment (animal health) of the broader pharma ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/CANIFARMA
• Facebookfacebook.com/canifarma
• LinkedInlinkedin.com/company/canifarma

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canifarma